ROCA Test for Ovarian Cancer Overview

Ovarian Cancer Testing

Ovarian cancer is the fifth most common cause of cancer-related deaths in women, and is often called the “silent killer” because the symptoms can be vague and difficult to diagnose at an early stage, when the survival rate is high.1 The sooner ovarian cancer can be detected, the earlier it can be diagnosed and treated, increasing the chance for survival.

The ROCA Test

The ROCA Test is a simple blood test that assesses a woman’s risk of having ovarian cancer. The test is intended for postmenopausal women over 50 years old and women at high risk of ovarian cancer.

Test Results

The ROCA Test reports a numerical score which represents a woman’s risk of having ovarian cancer. With this initial score, a doctor will be able to determine if further tests such as a transvaginal ultrasound scan are needed.

Benefits and Limitations

Understand the benefits, risks, limitations and contraindications of the ROCA Test.

Frequently Asked Questions

Have questions about the ROCA Test?  Get more answers here.

Patient Stories

The ROCA Test has been evaluated in clinical trials involving  over 200,000 women from across the UK. Read stories from some of these women.